
MITA PET Group rebrands as RMTA
The Radiopharmaceutical Manufacturers and Theranostics Alliance will expand beyond diagnostic radiopharmaceuticals to include theranostics.
Section
Operations, staffing, compliance, and the business of running a practice.

The Radiopharmaceutical Manufacturers and Theranostics Alliance will expand beyond diagnostic radiopharmaceuticals to include theranostics.

The 6F neurovascular access catheter is the company’s 3rd FDA-cleared catheter and is designed to broaden options for middle meningeal artery embolization and radial access procedures.

The Cancer Doesn’t Care Fund will support pilot programs, community partnerships, technology development, and policy research for earlier cancer detection.

Jonathan B. Kruskal, MB, ChB, PhD, and Douglas S. Katz, MD, received the society’s highest honor during the opening ceremony of the 2026 ARRS Annual Meeting in Pittsburgh.

The agency sent messages tied to more than 3,000 registered trials that appear to lack required results information on ClinicalTrials.gov.

The lawsuit alleges that Cleerly’s Ischemia, Plaque Analysis, and Compare products infringe 6 Heartflow patents.

The court dismissed Anthem Blue Cross claims against HaloMD and physician groups over No Surprises Act independent dispute resolution awards.

The recall covers Azurion interventional fluoroscopy systems after Philips identified cases where X-ray imaging may not start or may occur intermittently when using the wired foot switch.

The warning letter cites complaint handling, corrective action, and manufacturing-control issues tied to NAMIC angiographic control syringes used with radiographic contrast media.